How Much Weight Can You Realistically Lose on Medication?

by Burst Health

"How much will I lose?" is one of the first questions patients ask. It is also one of the questions practitioners are most careful with. The honest answer is that there is no single number that applies to every patient, but Australian clinical guidelines do reference target ranges that practitioners use to frame the conversation. Understanding what those targets look like, why the scale is only part of the picture, and what counts as clinically meaningful progress can help patients form realistic expectations before a consultation.

This article is general information only. It does not predict outcomes for any individual and does not describe the performance of any specific medication. It explains how Australian practitioners typically discuss realistic expectations and what tends to influence progress in clinical practice.

Why "Realistic" Is Set With Your Practitioner

Australian clinical guidelines, including the Royal Australian College of General Practitioners' resources and the Australian Obesity Management Algorithm, frame weight management as an individual clinical process rather than a target-driven one. A practitioner does not promise an outcome. The conversation is about:

  • what is achievable for this patient

  • what would be clinically meaningful in this patient's situation

  • what the patient is hoping for and whether that is well aligned with what is reasonable

  • how progress will be measured over time

  • what the plan looks like beyond the next few months

Setting expectations is itself part of good clinical care. A plan that starts with a clear, shared understanding tends to be a more workable plan.

The Targets Australian Clinical Guidelines Reference

The Australian Obesity Management Algorithm, developed jointly by the Australian and New Zealand Obesity Society, the Australian Diabetes Society, the Australian and New Zealand Metabolic and Obesity Surgery Society, and the Royal Australian College of General Practitioners, describes weight loss targets that practitioners use to plan and monitor management:

  • A weight loss of approximately 10 to 15 per cent of starting body weight for adults with a body mass index in the range of 30 to 40.

  • A weight loss of more than 15 per cent of starting body weight for adults with a body mass index above 40.

  • A 5 per cent reduction in body weight is widely recognised in obesity medicine as a clinically meaningful threshold at which patients commonly begin to see improvements in cardiometabolic markers, including blood pressure, glucose control, and lipid profile.

These targets are clinical reference points for the management plan as a whole. They are not predictions about a specific medication, and they are not promises about any individual patient. Practitioners use them to plan, to monitor, and to discuss progress, not as guarantees.

Why Outcomes Vary Between Individuals

Two patients on the same medication, with similar starting points, can have meaningfully different experiences. Several factors contribute to that variability:

  • baseline health, including any conditions that affect weight regulation

  • other medications and how they interact with treatment

  • age, sex, body composition, and other physical factors

  • diet, physical activity, sleep, and other lifestyle factors

  • the social and practical environment around the patient

  • mental health and the patient's overall capacity to engage with the broader plan

  • adherence to the prescribed plan over time

  • the stage of obesity-related complications, which the Edmonton Obesity Staging System is designed to capture

This is one reason a practitioner resists quoting a specific number for an individual patient at the start of treatment. The number is a function of the individual and the plan, not of the medication alone.

The Factors That Influence Response

When practitioners talk about response, they tend to focus on a few different inputs:

  • Adherence. Whether the patient is following the plan as prescribed, including the medication itself, follow-up appointments, and the broader lifestyle and behavioural components.

  • Lifestyle. Diet, physical activity, sleep, and stress all interact with medication response. Medication does not replace these factors.

  • Baseline metabolic state. Patients with different starting health pictures will respond differently. Practitioners look at the whole picture, not just the scale.

  • Time. Response is rarely linear. There are typically faster and slower phases, plateaus, and changes over time.

  • The broader plan. Patients who have access to dietitian, exercise physiology, or behavioural support tend to have a more complete plan, regardless of medication.

A practitioner integrates these inputs into the conversation about progress.

Looking Beyond the Scale: Edmonton Staging and Clinical Progress

Australian clinical practice increasingly looks beyond the number on the scale toward the impact of weight on the patient's medical, mental, and functional health. The Edmonton Obesity Staging System is one of the frameworks that captures this broader picture. The system classifies obesity severity from stage 0, where no obesity-related health issues are present, to stage 4, where end-stage complications dominate. Movement between stages, particularly a reduction in stage as complications improve or resolve, is a meaningful indicator of progress that may not be visible on a scale.

A patient may see clinically important changes well before significant weight loss appears, including:

  • improvements in blood pressure

  • better glucose control or HbA1c

  • improved lipid profile

  • better sleep, including reduced apnoea symptoms

  • reduced joint pain

  • improved mobility and functional ability

  • reduced reliance on certain medications, as a clinical decision by the practitioner

  • improved mood and quality of life

A practitioner will discuss which of these measures are meaningful for the individual patient and how they will be tracked, alongside weight, body mass index, and waist circumference.

How Practitioners Measure Progress

Weight on a scale is only one input. Practitioners typically consider a wider set of measures, depending on the patient:

  • Weight, interpreted as a trend over time rather than as a single value

  • Waist circumference, which adds cardiometabolic information independent of weight

  • Body mass index, calculated from height and weight, but always in context

  • Blood pressure, monitored at clinic visits or at home where appropriate

  • Pathology, including fasting glucose, HbA1c, lipid profile, liver function, and kidney function as clinically indicated

  • Symptoms, including joint pain, breathlessness, fatigue, and sleep disturbance

  • Functional measures, including the patient's capacity for daily activity

  • Quality of life and mood, often discussed in conversation rather than measured by a tool

  • Edmonton stage, where the practitioner uses the framework

Some of the most clinically meaningful changes show up in pathology and symptoms before they show up on the scale. A practitioner will discuss what is meaningful for the individual patient and how progress will be tracked.

Plateaus, Regain, and What They Typically Prompt

Most weight management trajectories are not straight lines. Patients commonly experience:

  • early phases where change feels rapid

  • middle phases where progress slows or pauses

  • plateaus that can last weeks or months

  • periods of regain when circumstances change or routines are disrupted

These patterns are well known clinically. They are not failures. When they appear, a practitioner will usually:

  • review what is happening in the broader life of the patient

  • look at adherence, lifestyle factors, and any new conditions or medications

  • adjust the plan if appropriate

  • discuss whether the medication, dose, or other components of the plan need to change

  • bring in additional support, including dietitian, exercise physiology, psychology, or other referrals where appropriate

A plateau or a regain is a reason to review the plan, not to abandon it. Australian clinical thinking increasingly recognises obesity as a chronic relapsing condition, where ongoing management is part of the picture rather than a one-off intervention.

Medication as One Component of a Broader Plan

Australian guidelines consistently describe medication as part of a broader plan, not as a standalone solution. The Australian Obesity Management Algorithm explicitly frames lifestyle support as the foundation for all patients, with additional interventions layered on for patients whose clinical situation supports them. Most plans include some combination of:

  • dietary changes appropriate to the patient

  • physical activity tailored to the patient's situation

  • behavioural support, which may involve psychology or counselling

  • management of related conditions, including sleep, mental health, and metabolic conditions

  • ongoing monitoring and follow-up

Patients who engage with the broader plan tend to be better placed than those who treat medication as a substitute for the rest. This is not a moral position. It is what the clinical evidence consistently shows.

When Practitioners Review and Adjust

Reviews are the natural points at which the plan is examined and updated. At a review, a practitioner will typically:

  • look at the data that has accumulated since the last review

  • discuss how the patient is feeling and what has changed

  • assess whether the current plan is still the right one

  • consider adjustments to medication, dose, supporting interventions, or referrals

  • agree the next set of steps with the patient

Patients can also ask for a review out of cycle if something changes. New health conditions, new medications, significant life events, or persistent side effects are all reasons to bring forward a review.

What "Realistic" Often Looks Like in Conversation

When practitioners discuss realistic expectations with patients, the conversation tends to cover:

  • the clinical targets practitioners reference, framed as ranges rather than specific numbers for an individual

  • the specific factors that may make this patient's path different

  • the difference between short-term and longer-term expectations

  • the role of plateaus and the likelihood of needing to adjust the plan

  • the importance of progress measures beyond the scale, including pathology and symptoms

  • what would prompt the practitioner to recommend stopping, changing, or continuing the medication

This is a conversation, not a contract. It is designed to give the patient a clear picture of the path ahead and to be revisited as the plan evolves.

Frequently Asked Questions

How much weight should I expect to lose on prescription weight loss medication?

There is no single number that applies to every patient. Australian clinical guidelines, including the Australian Obesity Management Algorithm, reference target ranges of 10 to 15 per cent for adults with a body mass index of 30 to 40 and more than 15 per cent for those above 40, and a 5 per cent reduction in body weight is widely recognised as a clinically meaningful threshold. A practitioner is the right person to discuss what is realistic for an individual.

How long until I notice a difference?

This varies between patients and between medications. A practitioner will discuss what to expect over the first weeks and months of treatment and how progress will be reviewed. Some clinically important changes, including in pathology or symptoms, can appear before significant weight changes.

What if I am not losing weight?

This is a reason to talk to the practitioner. A review can look at adherence, lifestyle factors, the broader plan, and whether changes to medication, dose, or supporting interventions are appropriate.

Do I have to lose weight quickly for the medication to be working?

No. Some of the most clinically meaningful changes show up in pathology and symptoms before they show up on the scale. A practitioner will discuss what is meaningful for the individual patient.

What happens after I reach a target?

A practitioner will discuss the longer-term plan with the patient. This often includes ongoing review, adjustments to medication where appropriate, and continued attention to the lifestyle and behavioural components of the plan. Obesity is increasingly understood as a chronic relapsing condition, and ongoing management is part of the picture.

What is the 5 per cent figure I keep seeing referenced?

A 5 per cent reduction in body weight is widely recognised in obesity medicine as a clinically meaningful threshold at which patients commonly begin to see improvements in cardiometabolic markers. It is referenced in clinical guidelines and is one of the figures practitioners use to discuss what counts as a meaningful response.

Further Information

For authoritative Australian information on weight management and clinical practice, useful sources include:

  • The Royal Australian College of General Practitioners (racgp.org.au), including its preventive activities and obesity resources

  • The National Health and Medical Research Council (nhmrc.gov.au), which maintains the national Clinical Practice Guidelines

  • The Australian Obesity Management Algorithm, developed by ANZOS, ADS, ANZMOSS, and RACGP

  • Healthdirect Australia (healthdirect.gov.au)

  • The Department of Health and Aged Care (health.gov.au)

  • The Australian Health Practitioner Regulation Agency (ahpra.gov.au)

This article is general information only and does not replace individualised medical advice. Please speak with a registered Australian healthcare practitioner about your own circumstances.

Back to Healthcare blog